In this study, we sought to define molecular heterogeneity in pediatric ALK+ ALCL (diagnostic and relapsed samples) using an integrated analysis including WES, RNA-sequencing, and DNA methylation array. This evidence concerns the gene ALK and anaplastic large cell lymphoma.